Mesothelin (MSLN) Human shRNA Plasmid Kit (Locus ID 10232)
CAT#: TL311377
MSLN - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector, 5µg of each construct provided
Need custom shRNA service?
Get a free quote
CNY 5,740.00
Cited in 2 publications. |
Product images
CNY 1,999.00
CNY 2,700.00
CNY 4,070.00
Specifications
Product Data | |
Product Name | Mesothelin (MSLN) Human shRNA Plasmid Kit (Locus ID 10232) |
Locus ID | 10232 |
UniProt ID | Q13421 |
Synonyms | MPF; SMRP |
Vector | pGFP-C-shLenti |
Format | Lentiviral plasmids |
Kit Components | MSLN - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector(Gene ID = 10232). 5µg purified plasmid DNA per construct29-mer scrambled shRNA cassette in pGFP-C-shLenti Vector, TR30021, included for free. |
RefSeq | NM_001177355, NM_005823, NM_013404, NM_005823.1, NM_005823.2, NM_005823.3, NM_005823.4, NM_005823.5, NM_013404.1, NM_013404.2, NM_013404.3, NM_013404.4, NM_001177355.1, NM_001177355.2, BC003512, BC003512.1, BC009272, NM_001177355.3, NM_005823.6 |
Summary | This gene encodes a preproprotein that is proteolytically processed to generate two protein products, megakaryocyte potentiating factor and mesothelin. Megakaryocyte potentiating factor functions as a cytokine that can stimulate colony formation of bone marrow megakaryocytes. Mesothelin is a glycosylphosphatidylinositol-anchored cell-surface protein that may function as a cell adhesion protein. This protein is overexpressed in epithelial mesotheliomas, ovarian cancers and in specific squamous cell carcinomas. Alternative splicing results in multiple transcript variants, at least one of which encodes an isoform that is proteolytically processed. [provided by RefSeq, Feb 2016] |
shRNA Design | These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service. |
Performance Guaranteed | OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples. For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred). |
Citations (2)
The use of this RNAi has been cited in the following citations: |
---|
Mesothelin promotes epithelial-to-mesenchymal transition and tumorigenicity of human lung cancer and mesothelioma cells
,He, X;Wang, L;Riedel, H;Wang, K;Yang, Y;Dinu, CZ;Rojanasakul, Y;,
Mol. Cancer
,PubMed ID 28288645
[MSLN]
|
Role of mesothelin in carbon nanotube-induced carcinogenic transformation of human bronchial epithelial cells
,He, X;Despeaux, E;Stueckle, TA;Chi, A;Castranova, V;Dinu, CZ;Wang, L;Rojanasakul, Y;,
Am. J. Physiol. Lung Cell Mol. Physiol.
,PubMed ID 27422997
[MSLN]
|
Documents
Product Manuals |
FAQs |
SDS |